Whole exome, targeted deep sequencing (TDS), RNA seq., and spatial biology profiling in patient-derived tissues of diffuse large B-cell lymphoma (DLBCL) identified a grade 1 dysfunctional CD8 fraction. The gene discussed is CD8A; the disease is diffuse large B-cell lymphoma.